Home » Yair Alerganti, B.Sc, Co-founder and Chief RA » Yair Alerganti, B.Sc, Co-founder and Chief RA Yair Alerganti, B.Sc, Co-founder and Chief RA About the Author View all posts by iykkv Q2 Pharma is developing small-molecule antivirulence agents against bacterial infections. Leave a Reply Click here to cancel reply.
